Genomate Health is thrilled to announce its participation in the 2024 Annual Meeting of the American Society of Clinical Oncology (#ASCO25).

ASCO is the leading global oncology conference, bringing together experts and innovators who are shaping the future of cancer treatment. At this prestigious event, Genomate Health will showcase its cutting-edge research in digital drug-assignment and predictive computational-driven oncology solutions, further solidifying our mission to enhance patient outcomes through precision medicine.

‍

Stay tuned for more insights from ASCO25 as we continue to push the boundaries of what’s possible in cancer care.

‍